% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • thirdmeinvestor thirdmeinvestor Sep 13, 2013 11:44 PM Flag

    Updated estimate for revenues from Kalydeco

    For Year 2013 the revenue from K would be more like 400 M, not 278 M that I projected last December:;_ylt=AgQZMVXMdcUsRGSa5W6UauXeAohG;_ylu=X3oDMTB1bDNjNmEwBHBvcwM0BHNlYwNNZWRpYU1zZ0JvYXJkc1hIUlVsdA--;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&q=Conservative+revenue+estimate+from+Kalydeco&in=b&inf=&sm=&bn=55fbc366-e0be-363e-88ff-c35e56e44242&stb=r&sto=d&lv=e&f=12

    Label expansions into all gating and residual mutations will start in 2014, and I project the revenue from K would be 650 M in 2014. For 2015-2016 there will be a quantum jump from CF revenues as I indicated earlier.

88.42+4.00(+4.74%)May 24 4:00 PMEDT